Combination treatment with ionising radiation and gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo (Q80564535)
Jump to navigation
Jump to search
scientific article published on 03 July 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Combination treatment with ionising radiation and gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo |
scientific article published on 03 July 2007 |
Statements
Combination treatment with ionising radiation and gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo (English)
A J Colquhoun
L A Mchugh
E Tulchinsky
M Kriajevska